Magnetic resonance imaging (MRI) is the most powerful tool for the early (differential)
diagnosis of multiple sclerosis (MS) and has been part of the International Panel criteria …

Natalizumab is a monoclonal antibody against α4-integrin approved for the treatment of
multiple sclerosis (MS) due to a positive effect on clinical and magnetic resonance imaging …

The relevance of cortical grey matter pathology in multiple sclerosis has become
increasingly recognized over the past decade. Unfortunately, a large part of cortical lesions …

Objectives To investigate whether a new magnetic resonance image (MRI) technique called
T2*-weighted fluid attenuation inversion recovery (FLAIR*) can differentiate between …

Objective To investigate posterior visual pathway damage in multiple sclerosis using
ultrahigh-field magnetic resonance imaging (MRI) at 7 Tesla (7 T), and to determine its …

Background. Brain lesions are common in neuromyelitis optica spectrum disorder (NMOsd)
and may resemble lesions of multiple sclerosis (MS). Objectives. To describe the imaging …

Abstract Objectives Seven-Tesla MRI demonstrated new pathological features of multiple
sclerosis (MS) using T2*-weighted sequences. However, a clinical MRI protocol at 7 T has …

MRI is the most powerful method in the detection of natalizumab-associated PML by
showing imaging patterns helpful in the differentiation between PML and multiple sclerosis …

Recently, a new MRI technique was developed at 3 Tesla (T), called fluid attenuated
inversion recovery*(FLAIR*). In this study, we implemented FLAIR* in an existing MS cohort …

Background: Virchow-Robin spaces (VRS) are associated with vascular and
neurodegenerative disease. In multiple sclerosis (MS), VRS have been associated with …